Sabra Healthcare REIT Inc
$ 20.49
0.74%
15 Apr - close price
- Market Cap 5,128,644,000 USD
- Current Price $ 20.49
- High / Low $ 20.57 / 20.18
- Stock P/E 31.78
- Book Value 11.21
- EPS 0.64
- Next Earning Report 2026-05-04
- Dividend Per Share $1.20
- Dividend Yield 5.93 %
- Next Dividend Date -
- ROA 0.03 %
- ROE 0.06 %
- 52 Week High 21.07
- 52 Week Low 15.97
About
As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 skilled nursing / transitional care facilities, (ii) 64 senior housing communities (?
Analyst Target Price
$21.92
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-12 | 2025-10-29 | 2025-08-04 | 2025-05-06 | 2025-02-25 | 2024-10-31 | 2024-08-07 | 2024-05-08 | 2024-02-27 | 2023-11-06 | 2023-08-07 | 2023-05-03 |
| Reported EPS | 0.11 | 0.1664 | 0.27 | 0.167 | 0.1692 | 0.13 | 0.1 | 0.11 | 0.07 | -0.07 | 0.09 | -0.04 |
| Estimated EPS | 0.17 | 0.182 | 0.18 | 0.14 | 0.17 | 0.16 | 0.15 | 0.14 | 0.13 | 0.13 | 0.1 | 0.11 |
| Surprise | -0.06 | -0.0156 | 0.09 | 0.027 | -0.0008 | -0.03 | -0.05 | -0.03 | -0.06 | -0.2 | -0.01 | -0.15 |
| Surprise Percentage | -35.2941% | -8.5714% | 50% | 19.2857% | -0.4706% | -18.75% | -33.3333% | -21.4286% | -46.1538% | -153.8462% | -10% | -136.3636% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-04 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.38 |
| Currency | USD |
Previous Dividend Records
| Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 | Nov 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-02-27 | 2025-11-28 | 2025-08-29 | 2025-05-30 | 2025-02-28 | 2024-11-29 | 2024-08-30 | 2024-05-31 | 2024-02-29 | 2023-11-30 |
| Amount | $0.3 | $0.3 | $0.3 | $0.3 | $0.3 | $0.3 | $0.3 | $0.3 | $0.3 | $0.3 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: SBRA
2026-04-15 20:10:15
Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced that it will release its first-quarter 2026 earnings on April 29, 2026, after the close of trading. The company will also host a conference call and webcast to discuss these results on April 30th at 10:00 a.m. Pacific Time. Sabra is a real estate investment trust specializing in healthcare properties across the United States and Canada.
2026-04-11 23:09:02
Sabra Health Care REIT, Inc. recently underwent a stock evaluation revision due to changing market conditions. The company's stock currently stands at $20.24, with a year-to-date return of 6.86% and a three-year return of 89.34%, outperforming the S&P 500 over that extended period. Technical indicators show mixed signals, with bullish signs in weekly MACD and KST but a bearish monthly RSI.
2026-04-08 18:39:42
This article provides a financial overview of Sabra Health Care REIT Inc (SBRA), detailing its profitability margins and comparing it to competitors. SBRA maintains a gross margin of 63.75%, an operating margin of 30.48%, and a net margin of 12.81%, with a Return on Equity (ROE) of 5.59%. The company, with a market capitalization of $5.06 billion, is benchmarked against industry leaders like PECO and MAC, highlighting its competitive position regarding efficiency.
2026-04-08 12:10:57
Tudor Investment Corp ET AL has acquired a new position in Sabra Healthcare REIT (NASDAQ:SBRA), purchasing 406,413 shares valued at approximately $7.58 million. Despite this institutional interest, Sabra Healthcare REIT faces challenges, including a high payout ratio of 187.5% and a recent miss on quarterly EPS, highlighting potential sustainability risks although analysts maintain a "Moderate Buy" consensus. The company recently declared a quarterly dividend of $0.30 per share, representing a 6.0% annual yield.
2026-04-07 10:40:53
Sound Income Strategies LLC increased its stake in Sabra Healthcare REIT (NASDAQ:SBRA) by 20.5% during the fourth quarter, purchasing 147,698 additional shares to own a total of 869,108 shares worth approximately $16.7 million. Despite the company missing recent quarterly EPS estimates and having a high payout ratio of 187.5%, analysts maintain a "Moderate Buy" consensus rating with an average target price of $22.00. Sabra Healthcare REIT, which pays a quarterly dividend of $0.30, saw its revenue increase by 16.2% year-over-year.
2026-04-03 16:39:50
Ten brokerages have given Sabra Healthcare REIT (NASDAQ:SBRA) an average "Moderate Buy" recommendation, with an average 12-month target price of $22.00, and some firms have recently raised their price targets. Despite missing Q4 EPS estimates and having a high dividend payout ratio of 187.5%, the company saw 16.2% revenue growth and is heavily owned by institutional investors. Sabra Healthcare REIT, which acquires and operates net-lease healthcare properties, is trading around $19.86 with a market cap of $5.01 billion.
